{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:33:41Z","timestamp":1771554821870,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of science and technology, R.O.C","award":["105-2320-B-005-006"],"award-info":[{"award-number":["105-2320-B-005-006"]}]},{"name":"Taichung Veterans General Hospital Research Program","award":["TCVGH-1063802B"],"award-info":[{"award-number":["TCVGH-1063802B"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198821","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T13:24:12Z","timestamp":1528809852000},"page":"e0198821","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tolerogenic \u03b22-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8283-6589","authenticated-orcid":true,"given":"Ya-Hsuan","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joung-Liang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Tung","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"key":"ref1","first-page":"1033","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"B Giannakopoulos","year":"2013"},{"key":"ref2","first-page":"15542","article-title":"Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI","volume":"95","author":"GM Iverson","year":"1998"},{"key":"ref3","first-page":"44","article-title":"Anti-beta2-glycoprotein I antibodies","volume":"1285","author":"R Willis","year":"2013"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","article-title":"beta(2)-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator","volume":"118","author":"K Gropp","year":"2011","journal-title":"Blood"},{"key":"ref5","first-page":"1644","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"G Girardi","year":"2003"},{"key":"ref6","first-page":"2340","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"F Fischetti","year":"2005"},{"key":"ref7","first-page":"211","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"VM Holers","year":"2002"},{"key":"ref8","first-page":"65","article-title":"T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals","volume":"43","author":"N Hattori","year":"2000"},{"key":"ref9","first-page":"192","article-title":"Autoreactive CD4+ T cells to \u03b22-glycoprotein I in patients with antiphospholipid syndrome","volume":"2","author":"M Kuwana","year":"2003"},{"key":"ref10","first-page":"1236","article-title":"Suppression of experimental antiphospholipid syndrome and systemic lupus erythematosus in mice by anti-CD4 monoclonal antibodies","volume":"37","author":"Y Tomer","year":"1994"},{"key":"ref11","first-page":"5303","article-title":"Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome","volume":"161","author":"M Blank","year":"1998"},{"key":"ref12","first-page":"776","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"MA Kutzler","year":"2008"},{"key":"ref13","first-page":"152","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"DC Tang","year":"1992"},{"key":"ref14","first-page":"240","article-title":"Immunologic responses to West Nile virus in vaccinated and clinically affected horses","volume":"226","author":"AH Davidson","year":"2005"},{"key":"ref15","first-page":"13","article-title":"Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon","volume":"64","author":"KA Garver","year":"2005"},{"key":"ref16","first-page":"139","article-title":"Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis","volume":"9","author":"N Fissolo","year":"2012"},{"key":"ref17","first-page":"1064","article-title":"FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis","volume":"11","author":"Y Kang","year":"2009"},{"key":"ref18","first-page":"78","article-title":"Early onset of autoimmunity in MRL\/++ mice following immunization with beta 2 glycoprotein I","volume":"101","author":"A Aron","year":"1995"},{"key":"ref19","article-title":"Beyond thrombosis: Anti-beta2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome","author":"CB Chighizola","year":"2018","journal-title":"J Autoimmun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/BOR.0000000000000200","article-title":"Update on the pathogenesis and reatment of the antiphospholipid syndrome","volume":"27","author":"CB Chighizola","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"ref21","first-page":"290","article-title":"Therapeutic HER2\/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu","volume":"10","author":"CC Lin","year":"2004"},{"key":"ref22","first-page":"704","article-title":"Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome","volume":"83","author":"M Karakantza","year":"2004"},{"key":"ref23","first-page":"2640","article-title":"beta2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome","volume":"198","author":"M Benagiano","year":"2017"},{"key":"ref24","first-page":"209","article-title":"T-cell anergy","volume":"16","author":"F Macian","year":"2004"},{"key":"ref25","first-page":"15","article-title":"Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway","volume":"15","author":"H Garren","year":"2001"},{"key":"ref26","first-page":"8241","article-title":"Coadministration of Plasmid DNA Constructs Encoding an Encephalitogenic Determinant and IL-10 Elicits Regulatory T Cell-Mediated Protective Immunity in the Central Nervous System","volume":"177","author":"S Schif-Zuck","year":"2006"},{"key":"ref27","first-page":"675","article-title":"Tolerizing DNA vaccines for autoimmune arthritis","volume":"39","author":"PP Ho","year":"2006"},{"key":"ref28","first-page":"553","article-title":"Plasmid-based gene therapy of diabetes mellitus","volume":"14","author":"GJ Prud'homme","year":"2007"},{"key":"ref29","first-page":"191ra82","article-title":"Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8(+) T cells in type 1 diabetes","volume":"5","author":"BO Roep","year":"2013"},{"key":"ref30","first-page":"1407","article-title":"Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1\/2 trial","volume":"64","author":"A Bar-Or","year":"2007"},{"key":"ref31","first-page":"611","article-title":"Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis","volume":"63","author":"H Garren","year":"2008"},{"key":"ref32","first-page":"221","article-title":"Towards new avenues in the management of lupus glomerulonephritis","volume":"12","author":"CC Mok"},{"key":"ref33","first-page":"455","article-title":". Current treatments of rheumatoid arthritis: from the 'NinJa' registry","volume":"8","author":"Y Saeki","year":"2012"},{"key":"ref34","first-page":"63","article-title":"Immunosuppressive drugs: the first 50 years and a glance forward","volume":"47","author":"AC Allison","year":"2000"},{"key":"ref35","first-page":"119","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"S Matsuda","year":"2000"},{"key":"ref36","first-page":"7i","article-title":"Tacrolimus versus ciclosporin immunosuppression: long-term outcome in renal transplantation","volume":"18","author":"WA Jurewicz","year":"2003"},{"key":"ref37","first-page":"1807","article-title":"The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells","volume":"30","author":"AM Woltman","year":"2000"},{"key":"ref38","first-page":"442","article-title":"Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells","volume":"49","author":"G Szabo"},{"key":"ref39","first-page":"226","article-title":"Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus","volume":"165","author":"AE Morelli","year":"2000"},{"key":"ref40","first-page":"3951","article-title":"Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells","volume":"105","author":"YR Lee","year":"2005"},{"key":"ref41","first-page":"3555","article-title":"Contrasting Impacts of Immunosuppressive Agents (Rapamycin, FK506, Cyclosporin A, and Dexamethasone) on Bidirectional Dendritic Cell-T Cell Interaction During Antigen Presentation","volume":"169","author":"H Matsue","year":"2002"},{"key":"ref42","first-page":"125","article-title":"Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells","volume":"28","author":"K Kogina","year":"2009"},{"key":"ref43","first-page":"1689","article-title":"Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen","volume":"97","author":"R Weissert","year":"2000"},{"key":"ref44","first-page":"8241","article-title":"Coadministration of plasmid DNA constructs encoding an encephalitogenic determinant and IL-10 elicits regulatory T cell-mediated protective immunity in the central nervous system","volume":"177","author":"S Schif-Zuck","year":"2006"},{"key":"ref45","first-page":"66","article-title":"Protective DNA vaccination against experimental autoimmune encephalomyelitis is associated with induction of IFNbeta","volume":"149","author":"J Wefer","year":"2004"},{"key":"ref46","first-page":"186","article-title":"Increased activity of interleukin-23\/interleukin-17 cytokine axis in primary antiphospholipid syndrome","volume":"218","author":"D Popovic-Kuzmanovic","year":"2013"},{"key":"ref47","first-page":"1035","article-title":"Th1\/Th2\/Th17\/Treg expression in cultured PBMCs with antiphospholipid antibodies","volume":"6","author":"J Xiao","year":"2012"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T15:31:15Z","timestamp":1540222275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198821"}},"subtitle":[],"editor":[{"given":"Suzannah","family":"Rutherford","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198821","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]}}}